Automated compounding reduces hospital costs and pharmacy errors

Researchers at the University of Arizona have found that automated compounding technology can eliminate compounding errors, reduces costs, and prevent disease outbreaks, according to a study published in <i>Hospital Pharmacy Journal</i>.

Researchers at the University of Arizona have found that automated compounding technology can eliminate compounding errors, reduces costs, and prevent disease outbreaks, according to a study published in Hospital Pharmacy Journal. Across 1,000 simulated dose preparations, the authors found that eliminating errors through automated compounding could save hospitals more than $280,000 annually. Meanwhile, a 2012 study in American Health & Drug Benefits found high costs from adverse drug events (ADEs) related to injectable medication errors, including compounding errors. The researchers said preventable ADEs due to injectable medications may cost up to $5 billion in the United States each year, while medical professional liability for inpatient ADEs from injectable medication costs up to $610 million annually. According to the authors, "reducing the risk for injectable medication errors is a clear target" for reducing unnecessary costs. Niels Erik Hansen, president and CEO of ARxIUM, a pharmacy solutions provider, asserts that "by reducing errors, decreasing need to outsource, and lowering the cost-per-dose of medication, automated compounding is ensuring patient safety and helping hospitals cut costs and save money."